Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies
Health Affairs · 01.11.2023 · 42 (11) · 1532-1540
DOI: 10.1377/hlthaff.2023.00527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, erschienen am 01.11.2023. Verfasst von Caroline Horrow und 1 weiteren Autor:innen. Beteiligte Einrichtung: Caroline Horrow, Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Clinical Decision-Making, Health Expenditures. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Caroline Horrow, Brigham and Women's Hospital, Boston, Massachusetts.
- Aaron S. Kesselheim (akesselheim@bwh.harvard.edu), Brigham and Women's Hospital.
Zitieren
APA
Horrow, C., & Kesselheim, A. S. (2023). Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies. Health Affairs, 42(11), 1532-1540. https://doi.org/10.1377/hlthaff.2023.00527
Vancouver
Horrow C, Kesselheim AS. Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies. Health Affairs. 2023;42(11):1532-1540. doi:10.1377/hlthaff.2023.00527
BibTeX
@article{Horrow2023,
author = {Horrow, Caroline and Kesselheim, Aaron S},
title = {Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies},
journal = {Health Affairs},
year = {2023},
volume = {42},
number = {11},
pages = {1532--1540},
doi = {10.1377/hlthaff.2023.00527}
}
EUVIMED